Clinical Trials
33 trialsUse of Tracking Devices to Locate Abnormalities During Invasive Procedures
National Institutes of Health Clinical Center (CC)
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
Janssen Research & Development, LLC
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
University of California, Irvine
MAGE-A4ᶜ¹º³²T for Multi-Tumor
USWM, LLC (dba US WorldMeds)
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Antelope Surgical Solutions, Inc
DP-04
AstraZeneca
PARIS-BIO
Region Stockholm
ARISTA
St. Antonius Hospital Gronau
iCCaRE
University of Ilorin Teaching Hospital
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
National Taipei University of Nursing and Health Sciences
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Memorial Sloan Kettering Cancer Center
Lutécio
Instituto do Cancer do Estado de São Paulo
LaserSAFE
University College, London
MOMENT
Prostate Cancer Clinical Trials Consortium
RF-2018-123683
IRCCS San Raffaele
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Massachusetts General Hospital
TA-P-OLIM
University Hospital, Ghent
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
University of Southern California
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
EVENTIDE
University of Aberdeen
Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
DINGO
St Vincent's Hospital, Sydney
TALENT
Prostate Cancer Clinical Trials Consortium
CLIQQC
Société Algérienne de Formation et Recherche en Oncologie
TRIPLE-SWITCH
Canadian Cancer Trials Group
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Acerand Therapeutics Limited
PPSARP
Lithuanian University of Health Sciences
MIDAS-SBRT
University Health Network, Toronto
MIDAS-Prostate
University Health Network, Toronto
ACCESS-PC
Rutgers, The State University of New Jersey
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Candel Therapeutics, Inc.